Extra-short vs. Non-extra-short Dental Implants Splinted on the Same Prosthesis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFundación Eduardo Anitua

About this trial

The main aim of this prospective study is to analyze the survival rate of short-length implants (\<6.5 mm) in subjects with partial edentulism. Non-short length implant will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Have planned a fixed multiple prosthesis supported by implants <6.5 mm in length and implants ≥ 6.5 mm in length within 15 days before the inclusion of the patient in the study.

Planning of supported prostheses from 2 to 4 implants dental

Have a previously performed CBCT (Cone Beam Computed Tomography)

Disqualifiers

Smokers> 10 cigarettes / day

Complete prostheses

Unitary prostheses

Trial population

Partial edentulism

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • BTI Implant

    Device

    BTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).

Treatment groups

102 Participants
are divided into 2 treatment groups
Group A: short-length implant (<6.5 mm)1 intervention
Group B: non-short length implant (≥6.5 mm)1 intervention

Trial outcomes

Primary outcomes

1

Survival of dental implants

Survival of dental implants at one year post-implantation

Time frame
1 year

Secondary outcomes

1

Marginal bone loss

Marginal bone loss at one year post-implantation

Time frame
1 year
2

Incidence of prosthetic or implant complications

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.